Verification evidence is still being completed.
PDF / print export
Affimed NV
Ladenburg, Germany
- Verified lead
- Shawn M. Leland
- Lead status
- STATUS: VERIFIED MARCH 2026
- Leadership verification
- Chief Executive Officer and Chairman of the Management Board
- 2026 technical specialization
- Innate Immunity
- Review cycle
- May 2026
- Full address
- Heidelberg, Germany
- Site coordinates
- Verification evidence is still being completed.
- Editorial review
- Memel Biotech editorial review
- Official leadership source
- Official Affimed board minutes confirming Shawn M. Leland as CEO.
- Editorial note
- Affimed is published as an active Heidelberg immunotherapy company with current CEO disclosure, a still-visible Heidelberg headquarters footprint, and a live oncology pipeline surface.
Innate Immunity
Clinical stage
Affimed is published as an active Heidelberg immunotherapy company with current CEO disclosure, a still-visible Heidelberg headquarters footprint, and a live oncology pipeline surface.
Review coverage
Leadership
Facility
Certifications
Capabilities
Partners
Sources
Quality
Editorial verificationMemel Biotech directory review sign-off
Report generated05 Jun 2026, 01:06
Company profile · Ladenburg, Germany
Affimed NV
Innate Immunity · Drug Development
Verified 14 Mar 2026 · 2 sources
Clinical
Affimed NV runs rock platform, nk cell engagement, and bispecific antibodies in Ladenburg, Germany.
Contact & location
- Address
- Heidelberg, Germany
- Website
- affimed.com
- Company page
- Lead
- Shawn M. Leland (verified ↗)
- Compliance
- Not yet on record
- Last reviewed
- 14 Mar 2026 (3mo ago)
- Scale
- Drug Development
- Capabilities
- ROCK Platform · NK Cell Engagement · Bispecific Antibodies
- Founded
- 2000
- Headcount
- 51-200
Clinical profileSTATUS: VERIFIED MARCH 2026
Shawn M. Leland
Chief Executive Officer and Chairman of the Management Board
Full addressHeidelberg, Germany
Site coordinatesVerification evidence is still being completed.
Review cycleMay 2026
Physical site source
Official Affimed corporate presentation describing the company as headquartered in Heidelberg, Germany.
Open sourceDrug Development
Ladenburg, Germany. Innate Immunity. Review completed on 14 Mar 2026.
EMA
Clinical stage
Innate Immunity
Affimed is published as an active Heidelberg immunotherapy company with current CEO disclosure, a still-visible Heidelberg headquarters footprint, and a live oncology pipeline surface.
Editorial note
Affimed is published as an active Heidelberg immunotherapy company with current CEO disclosure, a still-visible Heidelberg headquarters footprint, and a live oncology pipeline surface.
FULL TRUST REVIEW COMPLETE
Shown only when all seven trust checks are fully mapped in the directory.
Current review cycleMarch 2026
Capabilities
Core capabilities
Primary declared technical activities and areas of operating focus.
ROCK Platform
NK Cell Engagement
Bispecific Antibodies
Verification source dossier
Verification source dossier
Official source set used to support leadership, physical-site, certification, and watch-note evidence.
Infrastructure
Declared infrastructure
Flow Cytometry Suites
Regulatory posture
Quality system coverage
GMP / GLP / ISO-13485 / FDA-Inspected are global quality-system standards. "Verified active" means the directory confirmed the certification is current; "Review in progress" means the cert status is currently being re-verified.
- GMP
- REVIEW IN PROGRESS 2026
- GLP
- REVIEW IN PROGRESS 2026
- ISO-13485
- REVIEW IN PROGRESS 2026
- FDA-Inspected
- REVIEW IN PROGRESS 2026
Verification history
Verification history
14 Mar 2026: Executive identity confirmed via official management disclosure.
14 Mar 2026: Full trust review completed.
FAQ
Frequently asked questions
- Where is Affimed NV located?
- Affimed NV operates from Heidelberg, Germany, Ladenburg, Germany.
- Who runs Affimed NV?
- Affimed NV is led by Shawn M. Leland, Chief Executive Officer and Chairman of the Management Board. Verified 14 Mar 2026.
- What does Affimed NV do?
- Affimed NV runs rock platform, nk cell engagement, and bispecific antibodies in Ladenburg, Germany. Core capabilities: ROCK Platform, NK Cell Engagement, Bispecific Antibodies.
Editorial context
Related technical briefs
Briefs that name Ladenburg as a covered market or city.